Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Findings from two studies reveal advancements in stem cell-derived treatment options to treat type 1 diabetes. Results from the FORWARD study, also simultaneously published in the New England Journal ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data ...

Diabetes in pets, especially in dogs and cats, can show symptoms similar to those in humans. Early detection is essential to ...

The American College of Lifestyle Medicine published new clinical guidance on lifestyle interventions for the treatment and ...

Need help navigating life with diabetes? You can always Ask D’Mine… Welcome back to our weekly Q&A column, hosted by longtime type 1 and diabetes author Wil Dubois. Today, Wil’s focusing on ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...